Skip to main content

EPM Application Market 2023 Forecast

Technavio logo
image: technavio.com
A former Mitchell & Co. Outstanding CEO honoree, John Klein serves as chairman of Cambridge Therapeutics, which he founded in 2011 to deliver combination drug therapies. Concurrently, John Klein is the chairman and CEO of the Alpine, NJ-based Bilogix, LLC, through which he provides enterprise performance management (EPM) solutions to business clients to better inform their decision-making processes and improve operational performance.

According to Technavio, the EPM application market is expected to grow by more than $2 billion by 2023, which equates to a compound annual growth rate of nearly 9 percent. Technavio has been monitoring the global market since 2015 and presented its findings in its recent 132-page market analysis report.

The report states that market growth will be driven by demand for cloud-based EPM solutions in addition to companies seeking to satisfy changing regulations. Given the volume and sensitive nature of data transferred across various industries, government bodies are increasingly approving new regulations concerning data collection, storage, and utilization.

Banking, financial services, and insurance companies are expected to generate the most revenue for EPM providers, while telecom and IT ranks second. Growth is also expected in manufacturing and healthcare. Moreover, the report projects the Asia-Pacific region as having the brightest outlook for the EPM market.
Labels:

Comments

Post a Comment

Popular posts from this blog

Bilogix Implements Enterprise Performance Management Solutions

The chairman of Alpine, New Jersey-based Cambridge Therapeutics, John Klein offers next-generation solutions in areas ranging from combination therapies to drug delivery. Building on his experience with Cambridge Therapeutics, John Klein recently launched Bilogix in Alpine, NJ, a provider of enterprise performance management (EPM) consulting services. Encompassing processes and applications, the EPM approach is one that transforms key performance indicator (KPI) data into highly accurate ways of analyzing, monitoring, measuring, and forecasting organizational results. It adds value through bringing focus on the details of how strategic plans are envisioned and implemented, as well as how challenges and inconsistencies are addressed when they occur. This ensures that resources are utilized more efficiently toward defined goals, at both the operational and tactical levels. At the same time, the effects of business intelligence investments can be tracked via a dashboard and r...
Post a Comment
Read more

Costs Associated with Enterprise Performance Management

An award-winning pharmaceutical executive based in Alpine, New Jersey, John Klein founded Cambridge Therapeutics and Bi-Logix, LLC, in 2011 and 2015, respectively (both located in Alpine, NJ). Bi-Logix, LLC, is an enterprise performance management (EPM) firm that helps companies obtain sustainable measured performance via its proprietary business solutions and methodology, which is copyrighted by John Klein. EPM solutions help businesses improve their IT infrastructure and increase overall corporate efficiency, which, in turn, helps them cut costs and increase revenue. While there are costs associated with EPM implementation, its long-term benefits significantly outweigh the impact of short-term spending. In addition to paying for EPM software licensing and maintenance, businesses might also have to budget costs for database software to help run the EPM. Other costs that might be accrued include the maintenance and upgrading of hardware, as well as fees for third-party inte...
Post a Comment
Read more

New Jersey Aims to Ensure That All Children Have Health Insurance

John Klein has led Teaneck, New Jersey-based Cambridge Therapeutics since founding the pharmaceutical products manufacturer nearly a decade ago. He and his company provide a range of customer-friendly medical packaging options designed to increase patient adherence to prescription regimens. In addition to his role with Cambridge Therapeutics, John Klein is a board member with Hackensack Meridian Health Hospitals and regularly studies emerging information in the healthcare field in his state. In order to care for the most vulnerable of its citizens, the state of New Jersey oversees NJFamilyCare , a publicly funded insurance program that offers free or affordable health insurance for individuals of all ages. The program entitles policy holders to obtain visits to physicians, dentists, mental health professionals, and vision care specialists, as well as hospital services. However, the research group New Jersey Policy Perspective noted that the number of children enrolled in NJFamilyCar...
Post a Comment
Read more